Related Experiment Videos
SAR by MS: a ligand based technique for drug lead discovery against structured RNA targets
Eric E Swayze1, Elizabeth A Jefferson, Kristin A Sannes-Lowery
1Ibis Therapeutics, A Division of Isis Pharmaceuticals, Inc., 2292 Faraday Avenue, Carlsbad, California 92008, USA. eswayze@isisph.com
Journal of Medicinal Chemistry
|August 23, 2002
Abstract:
A technique for lead discovery vs RNA targets utilizing mass spectrometry (MS) screening methods is described. The structure-activity relationships (SAR) derived from assaying weak binding motifs allows the pharmacophores discovered to be elaborated via "SAR by MS" to higher affinity ligands. Application of this strategy to a subdomain of the 23S rRNA afforded a new class of compounds with functional activity.